Following an increased interest in its SpectroSens optical microchip platform technology, Stratophase, a venture capital-funded spinout from the University of Southampton in the UK, has doubled its sensor chip manufacturing capability with a move to a larger facility. The real-time chemical and biochemical measurement and detection company’s new building is three times larger than its old one, and it is fitted with offices, meeting rooms and high-tech laboratory space, with the option to expand further. The SpectroSens technology is suitable for use in applications including biodetection and test monitoring of industrial processes.